Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, were originally developed as diabetes treatments, but they are now widely used for obesity due to their significant weight-loss effects
In an extensive phase III clinical program including patients from across the disease spectrum, treatment with oral semaglutide resulted in effective glycemic control, reductions in body weight, and decreases in systolic blood pressure when used as monotherapy or in combination with other glucose-lowering therapies
Insoluble Fiber: Whats the Difference
Larazotide is a peptide designed specifically to address intestinal permeability, commonly known as leaky gut. This condition occurs when the tight junctions in the intestinal lining loosen, allowing toxins, pathogens, and undigested food particles to escape into the bloodstream
Efficacy of quercetin and quercetin loaded chitosan nanoparticles against cisplatin-induced renal and testicular toxicity via attenuation of oxidative stress, inflammation, and apoptosis